OraSure Technologies Inc
NASDAQ:OSUR

Watchlist Manager
OraSure Technologies Inc Logo
OraSure Technologies Inc
NASDAQ:OSUR
Watchlist
Price: 3.88 USD 0.78% Market Closed
Market Cap: 289.4m USD
Have any thoughts about
OraSure Technologies Inc?
Write Note

OraSure Technologies Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OraSure Technologies Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
OraSure Technologies Inc
NASDAQ:OSUR
Change in Working Capital
$23.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
21%
Haemonetics Corp
NYSE:HAE
Change in Working Capital
-$166.9m
CAGR 3-Years
-37%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
ICU Medical Inc
NASDAQ:ICUI
Change in Working Capital
$64.2m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
17%
Align Technology Inc
NASDAQ:ALGN
Change in Working Capital
-$310.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Change in Working Capital
-$58.6m
CAGR 3-Years
-92%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Merit Medical Systems Inc
NASDAQ:MMSI
Change in Working Capital
-$33.9m
CAGR 3-Years
-24%
CAGR 5-Years
10%
CAGR 10-Years
-11%
No Stocks Found

OraSure Technologies Inc
Glance View

Market Cap
289.4m USD
Industry
Health Care

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 785 full-time employees. The firm's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

OSUR Intrinsic Value
4.07 USD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is OraSure Technologies Inc's Change in Working Capital?
Change in Working Capital
23.8m USD

Based on the financial report for Sep 30, 2024, OraSure Technologies Inc's Change in Working Capital amounts to 23.8m USD.

What is OraSure Technologies Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
21%

Over the last year, the Change in Working Capital growth was 2 549%.

Back to Top